Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts

This publication has 30 references indexed in Scilit:

• Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study.
  Journal of Clinical Oncology, 1991
• A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patients
  Cancer Chemotherapy and Pharmacology, 1991
• Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiency
  Biochemical Pharmacology, 1990
• The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group.
  Journal of Clinical Oncology, 1989
• Evaluation of N-(5-indanylsulfonyl)-N?-(4-chlorophenyl)-urea against xenografts of pediatric rhabdomyosarcoma
  Cancer Chemotherapy and Pharmacology, 1989
• Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenografT
  Biochemical Pharmacology, 1989
• A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.
  Journal of Clinical Oncology, 1988
• Human liver methenyltetrahydrofolate synthetase: improved purification and increased affinity for folate polyglutamate substrates
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
• Analysis of folate cofactor levels in tissues using high-performance liquid chromatography
  Analytical Biochemistry, 1983
• A radioimmunoassay for measurement of serum thymidine
  Analytical Biochemistry, 1973